← Eichor
Study identifier: NCT04696029 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma

Condition: Medulloblastoma  ·  Sponsor: Giselle Sholler

PhasePhase 2
Planned participants118
Who can joinAll sexes, N/A to 21 Years
Healthy volunteersNo

About this study

Difluoromethylornithine (DFMO) will be used in an open label, multicenter, study as Maintenance Therapy for Molecular High Risk/Very High Risk and Relapsed/Refractory Medulloblastoma.

This description comes directly from the study's public registry record.

Talk to the study team

BCC Enroll  ·  7175310003  ·  BCCEnroll@pennstatehealth.psu.edu

Always discuss trial participation with your own doctor first.

Locations (24)

Arkansas Children's HospitalLittle Rock, Arkansas, United StatesRecruiting
UCSF Benioff Children's Hospital OaklandOakland, California, United StatesRecruiting
Rady Children's HospitalSan Diego, California, United StatesRecruiting
Stanford UniversityStanford, California, United StatesRecruiting
Connecticut Children's HospitalHartford, Connecticut, United StatesRecruiting
Nicklaus Children's HospitalMiami, Florida, United StatesRecruiting
Arnold Palmer Hospital for ChildrenOrlando, Florida, United StatesRecruiting
All Children's Hospital Johns Hopkins MedicineSt. Petersburg, Florida, United StatesRecruiting
St. Joseph's Children's HospitalTampa, Florida, United StatesRecruiting
Kapiolani Medical Center for Women and ChildrenHonolulu, Hawaii, United StatesRecruiting
Advocate Aurora Research InstituteChicago, Illinois, United StatesRecruiting
Kentucky Children's HospitalLexington, Kentucky, United StatesRecruiting

+ 12 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04696029